HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes.

AbstractBACKGROUND:
Early diagnosis of acute coronary syndrome (ACS) is frequently a challenging task, while immediate risk stratification remains crucial for the prompt implementation of appropriate therapy in this setting. Employing markers that increase rapidly after the symptom onset may enhance triage and therapeutic decision-making in patients suspected for ACS. Myeloperoxidase (MPO) exerting proinflammatory and pro-oxidative properties is suggested as a reliable early marker for ACS associated with unfavourable clinical outcome. We assessed the diagnostic efficacy of plasma MPO alone or in combination with cardiac troponin I (cTnI) for detecting ACS in patients presenting with chest pain initiating within 6h before the hospital admission.
MATERIAL AND METHODS:
A study group consisted of 253 patients diagnosed with ACS and 47 subjects having other heart disease or unspecified chest pain. Clinically healthy volunteers (n=124) served as controls. MPO concentration was measured in plasma (Abbott Diagnostics, USA), while serum was assayed for cTnI, creatine-kinase MB, lipids, glucose, creatinine, brain natriuretic peptide type B and C-reactive protein.
RESULTS:
Both MPO and cTnI values were significantly lower in non-ACS subjects than in patients with ACS. At 97·5th percentile as cut-off, the superiority of MPO over cTnI was observed in patients with unstable angina and non-ACS subjects. Considerably higher MPO concentrations were demonstrated in the troponin-negative ACS patients on admission who became troponin-positive after 6h. Combined evaluation of MPO and cTnI possessed remarkably higher sensitivity than assessment of cTnI alone in all patients with ACS.
CONCLUSIONS:
Myeloperoxidase substantially facilitates the early diagnosis of ACS.
AuthorsMarcin Sawicki, Grazyna Sypniewska, Marek Kozinski, Marzenna Gruszka, Magdalena Krintus, Karolina Obonska, Marta Pilaczynska-Cemel, Jacek Kubica
JournalEuropean journal of clinical investigation (Eur J Clin Invest) Vol. 41 Issue 6 Pg. 667-71 (Jun 2011) ISSN: 1365-2362 [Electronic] England
PMID21226709 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2011 The Authors. European Journal of Clinical Investigation © 2011 Stichting European Society for Clinical Investigation Journal Foundation.
Chemical References
  • Biomarkers
  • Troponin I
  • Peroxidase
Topics
  • Acute Coronary Syndrome (diagnosis)
  • Adult
  • Aged
  • Area Under Curve
  • Biomarkers (blood)
  • Case-Control Studies
  • Chest Pain (etiology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peroxidase (blood)
  • Predictive Value of Tests
  • Risk Assessment
  • Time Factors
  • Troponin I (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: